These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22854114)

  • 1. Endoscopic treatment of vesicoureteral reflux in children with subureteral dextranomer/hyaluronic acid injection: a single-centre, 7-year experience.
    Biočić M; Todorić J; Budimir D; Cvitković Roić A; Pogorelić Z; Jurić I; Šušnjar T
    Can J Surg; 2012 Oct; 55(5):301-6. PubMed ID: 22854114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F; Colhoun E; Puri P
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.
    Puri P; Chertin B; Velayudham M; Dass L; Colhoun E
    J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children.
    Oswald J; Riccabona M; Lusuardi L; Bartsch G; Radmayr C
    Urology; 2002 Nov; 60(5):894-7; discussion 898. PubMed ID: 12429323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
    Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
    J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
    Yu RN; Roth DR
    Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
    Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
    Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
    Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
    J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Our experience using various injectable materials for the endoscopic treatment of vesicoureteral reflux].
    Cabezalí Barbancho D; Gómez Fraile A; López Vázquez F; López Díaz M; Aransay Bramtot A
    Arch Esp Urol; 2008 Mar; 61(2):269-77. PubMed ID: 18491746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureteroneocystostomy after failed dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux treatment.
    Moreira-Pinto J; Osório A; Pereira J; Sousa C; de Castro JL; Réis A
    J Pediatr Urol; 2013 Oct; 9(5):665-9. PubMed ID: 22906586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
    Moore K; Bolduc S
    J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
    Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
    J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux.
    Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM
    J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term followup after endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer in patients with neurogenic bladder.
    Polackwich AS; Skoog SJ; Austin JC
    J Urol; 2012 Oct; 188(4 Suppl):1511-5. PubMed ID: 22910250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
    Kirsch AJ; Perez-Brayfield MR; Scherz HC
    J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.